triazoles has been researched along with digoxin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abacioğlu, N; Cakici, I; Ersoy, S; Kanzik, I; Mataraci, N; Tunçtan, B | 1 |
| Barbhaiya, RH; Dockens, RC; Greene, DS | 1 |
| Kleinermans, D; Nichols, D; Purkins, L; Wood, N | 1 |
| Nogid, A; Pham, DQ; Plakogiannis, R | 1 |
| Balez, S; Belleli, R; Robeva, A; Sechaud, R | 1 |
| Choo, HW; Fang, J; Heera, J; Vourvahis, M | 1 |
| Akhtar, S; Desai, A; Goldwater, R; Han, D; Howieson, C; Kowalski, D; Lademacher, C; Lasseter, KC; Rammelsberg, D; Townsend, R; Yamazaki, T | 1 |
| Bullard, HM; Churpek, J; Knoebel, RW; Shumaker, AC | 1 |
| Chan, LN; Chen, KF; Lin, YS | 1 |
| Hop, CECA; Hu, M; Humphreys, WG; Khojasteh, SC; Lai, Y; Wei, C; Wright, MR; Zhang, D | 1 |
2 review(s) available for triazoles and digoxin
| Article | Year |
|---|---|
Sitagliptin: a novel agent for the management of type 2 diabetes mellitus.
Topics: Diabetes Mellitus, Type 2; Digoxin; Drug Interactions; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Metformin; Pyrazines; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; Thiazolidinediones; Triazoles | 2008 |
Intestinal Excretion, Intestinal Recirculation, and Renal Tubule Reabsorption Are Underappreciated Mechanisms That Drive the Distribution and Pharmacokinetic Behavior of Small Molecule Drugs.
Topics: Animals; Digoxin; Half-Life; Humans; Intestinal Mucosa; Kidney Tubules; Pyrazoles; Pyridines; Pyridones; Renal Reabsorption; Small Molecule Libraries; Triazoles | 2021 |
5 trial(s) available for triazoles and digoxin
| Article | Year |
|---|---|
Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers.
Topics: Adult; Antidepressive Agents, Second-Generation; Cardiotonic Agents; Cross-Over Studies; Digoxin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Electrocardiography; Heart Rate; Humans; Male; Piperazines; Triazoles | 1996 |
Voriconazole does not affect the steady-state pharmacokinetics of digoxin.
Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Cardiotonic Agents; Digoxin; Double-Blind Method; Drug Combinations; Drug Interactions; Humans; Male; Plasma; Pyrimidines; Triazoles; Voriconazole | 2003 |
Absence of an effect of a single-dose deferasirox on the steady-state pharmacokinetics of digoxin.
Topics: Adult; Area Under Curve; Benzoates; Cardiotonic Agents; Cross-Over Studies; Deferasirox; Digoxin; Drug Interactions; Humans; Iron Chelating Agents; Male; Middle Aged; Triazoles | 2008 |
The effect of maraviroc on the pharmacokinetics of digoxin in healthy volunteers.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; CCR5 Receptor Antagonists; Cross-Over Studies; Cyclohexanes; Digoxin; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Healthy Volunteers; Humans; Male; Maraviroc; Middle Aged; Triazoles; Young Adult | 2014 |
Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects.
Topics: Adult; Area Under Curve; Atorvastatin; Digoxin; Female; Healthy Volunteers; Humans; Male; Membrane Transport Proteins; Metformin; Methotrexate; Middle Aged; Nitriles; Pyridines; Triazoles; Young Adult | 2017 |
3 other study(ies) available for triazoles and digoxin
| Article | Year |
|---|---|
Effects of platelet-activating factor antagonists WEB 2086 and BN 50730 on digoxin-induced arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Azepines; Digoxin; Female; Guinea Pigs; Hemodynamics; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Thienopyridines; Triazoles | 1995 |
Posaconazole-digoxin drug-drug interaction mediated by inhibition of P-glycoprotein.
Topics: Aged; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Atrial Fibrillation; Digoxin; Drug Interactions; Female; Humans; Triazoles | 2019 |
PBPK modeling of CYP3A and P-gp substrates to predict drug-drug interactions in patients undergoing Roux-en-Y gastric bypass surgery.
Topics: Acetaminophen; Administration, Oral; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Digoxin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Gastric Bypass; Gastrointestinal Absorption; Hepatobiliary Elimination; Humans; Intestinal Elimination; Metabolic Clearance Rate; Midazolam; Models, Biological; Obesity, Morbid; Postoperative Period; Triazoles; Verapamil | 2020 |